SOURCE-LINKED STUDY SUMMARY
Anabolic-Androgenic Steroid Use, All-Cause Mortality, and Major Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
Abstract summarizedQuality not appraised
- What was studied
- A systematic review examined mortality, cardiovascular disease and cardiac function after anabolic-androgenic steroid use.
- Who / model studied
- Fifteen reports; mortality pooled from three observational cohorts. Former-user imaging studies were analyzed separately.
- Studied dose & schedule
- Nonmedical steroid exposure versus nonexposed comparators. Compounds, doses, co-use and follow-up differed; this was not a randomized drug trial.
- What the study found
- Mortality was associated with steroid exposure: risk ratio 2.57 (95% CI 1.98–3.33). The prediction interval was wide, 0.47–13.87. Former users had worse global longitudinal strain; the pooled ejection-fraction result was uncertain.
- Limitations & context
- Residual confounding, different follow-up and few cohorts prevent a causal or compound-specific risk estimate. Cardiovascular event estimates came from one large cohort. Former-user comparisons do not establish an individual recovery trajectory.
Read summary source ↗ · Prepared 10/28/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.3390/medsci14060678